Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Jul 8, 2026

Biochemical Measurement of Neonatal Hypoxia

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

Neonatal diabetes.

J P H Shield¹

¹Bristol Royal Hospital for Children, Department of Child Health, Bristol, UK. j.p.h.shield@bristol.ac.uk

Hormone Research

|February 7, 2008

Summary

This summary is machine-generated.

Neonatal diabetes mellitus results from genetic conditions affecting pancreatic development or function. Advances in understanding specific types are improving treatment options for affected infants.

Related Concept Videos

Pathophysiology of Diabetes

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Diabetes Mellitus: Introduction

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

Type I Diabetes III: Clinical Manifestations

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...

Type I Diabetes II: Pathophysiology

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A longitudinal study investigating change in BMI z-score in primary school-aged children and the association of child BMI z-score with parent BMI.

BMC public health·2020

Same author

Continuing rise of Type 2 diabetes incidence in children and young people in the UK.

Diabetic medicine : a journal of the British Diabetic Association·2018

Same author

Adolescent experiences of anti-obesity drugs.

Clinical obesity·2015

Same author

Adolescents' views and experiences of treatments for Type 2 diabetes: a qualitative study.

Diabetic medicine : a journal of the British Diabetic Association·2014

Same author

Can foster care ever be justified for weight management?

Archives of disease in childhood·2013

Same author

Clinical presentation of 6q24 transient neonatal diabetes mellitus (6q24 TNDM) and genotype-phenotype correlation in an international cohort of patients.

Diabetologia·2013

Area of Science:

Genetics
Endocrinology
Developmental Biology

Background:

Nine genetic conditions causing neonatal diabetes mellitus identified in 12 years.
Pathways include pancreatic development failure, islet cell dysfunction, and beta-cell destruction.
Focus on three conditions with recent advances in pathology and treatment.

Purpose of the Study:

To review advances in understanding neonatal diabetes mellitus.
To highlight progress in three specific genetic conditions: transient neonatal diabetes mellitus, permanent neonatal diabetes due to channelopathies, and immune dysregulation, polyendocrinopathy, enteropathy X-linked syndrome.

Main Methods:

Literature review of genetic conditions causing neonatal diabetes mellitus.
Focus on recent research concerning pancreatic development and islet cell function.

Related Experiment Videos

Last Updated: Jul 8, 2026

Biochemical Measurement of Neonatal Hypoxia

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

Analysis of treatment strategies for specific neonatal diabetes subtypes.

Main Results:

Significant progress in understanding the pathology of transient neonatal diabetes mellitus.
Enhanced knowledge of permanent neonatal diabetes linked to channelopathies.
Increased insights into immune dysregulation, polyendocrinopathy, enteropathy X-linked syndrome.

Conclusions:

Effective neonatal diabetes treatment hinges on understanding disease mechanisms.
Expanding knowledge of pancreatic development and physiology offers new treatment avenues for some patients.